Hutchmed begins phase-three trials of lymphoma therapy in China
23rd Mar 2026 10:21
(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China. Read More
| Price | 216.00p on 31-03-2026 at 18:35:13 |
|---|---|
| Change | 0.00p 0% |
| Buy | 219.00p |
| Sell | 216.00p |
| Last Trade: | Buy 10,000.00 at 220.6299p |
| Day's Volume: | 28,567 |
| Last Close: | 216.00p |
| Open: | 219.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 214.00p - 219.00p |
| 52wk Range: | 187.50p - 292.00p |
| Market Capitalisation: | £1.86b |
| VWAP: | 216.39282p |
| Shares in Issue: | 859.52m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 10,000 | 220.6299p | Suspected BUY Trade |
16:42:29 - 31-Mar-26 |
| Sell* | 28 | 216.00p | Uncrossing Trade |
16:35:26 - 31-Mar-26 |
| Sell* | 60 | 216.00p | Ordinary |
16:29:56 - 31-Mar-26 |
| Buy* | 36 | 219.00p | Automatic Execution |
16:28:57 - 31-Mar-26 |
| Buy* | 969 | 216.00p | Automatic Execution |
16:28:55 - 31-Mar-26 |
| Sell* | 55 | 214.00p | Automatic Execution |
15:52:26 - 31-Mar-26 |
| Buy* | 4,031 | 216.00p | Automatic Execution |
15:38:57 - 31-Mar-26 |
| Sell* | 2,810 | 213.2312p | Ordinary |
15:38:51 - 31-Mar-26 |
| Sell* | 6,500 | 214.00p | Ordinary |
15:31:33 - 31-Mar-26 |
| Buy* | 12 | 216.30p | Ordinary |
15:15:55 - 31-Mar-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 23rd Mar 2026 7:00 am | RNS-R | HUTCHMED Initiates Phase III Trial of HMPL-760 |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |
| 6th Mar 2026 8:30 am | RNS | Directorate change |
| 5th Mar 2026 1:00 pm | RNS-R | Publication of Form 20-F |
| 5th Mar 2026 11:00 am | RNS | 2025 Full Year Results and Business Updates |
| 4th Mar 2026 8:30 am | RNS-R | HUTCHMED Initiates Global Trial of ATTC Candidate |